DS
Dilip Singh Karan Singh Rao
About Dilip Singh Karan Singh Rao
Data last updated:
Dilip Singh Karan Singh Rao has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Kdpress Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kdpress Pharmaceuticals Private Limited at ₹1.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kdpress Pharmaceuticals Private Limited U52100MH2020PTC338588 | Director | 05 Feb 2021 | 2020 | ₹1.17 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dilip Singh Karan Singh Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dilip Singh Karan Singh Rao
Dilip Singh Karan Singh Rao has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Kdpress Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kdpress Pharmaceuticals Private Limited at ₹1.17 Cr (FY 2025).
Dilip Singh Karan Singh Rao is associated with 1 company as Director, including Kdpress Pharmaceuticals Private Limited (₹1.17 Cr).
Dilip Singh Karan Singh Rao has expertise in General Business.
Dilip Singh Karan Singh Rao has 5 years in corporate governance.
By reported revenue, the largest current company of Dilip Singh Karan Singh Rao is Kdpress Pharmaceuticals Private Limited, with revenue of ₹1.17 Cr (FY 2025).
Dilip Singh Karan Singh Rao currently holds positions at 1 company: Kdpress Pharmaceuticals Private Limited (₹1.17 Cr).